Get started
Author

Kiran Kumar Mustyala

Institution: Osmania University
Observed institution: Osmania University
ORCID: 0000-0001-9355-3517
Observed ORCID: 0000-0001-9355-3517
OpenAlex ID: A5077027168
Structure-based drug design, synthesis and screening of MmaA1 inhibitors as novel anti-TB agents
2020 · Hymavathi Veeravarapu, Vasavi Malkhed, et al. · Molecular Diversity · 21
Identification of novel leads applyingin silicostudies for Mycobacterium multidrug resistant (MMR) protein
2013 · Vasavi Malkhed, Kiran Kumar Mustyala, et al. · Journal of Biomolecular Structure and Dynamics · 21
Homology modeling and virtual screening studies of FGF-7 protein—a structure-based approach to design new molecules against tumor angiogenesis
2016 · Rajender Vadija, Kiran Kumar Mustyala, et al. · Journal of Chemical Biology · 18
PDF
Molecular dynamic simulations of Co(III) and Ru(II) polypyridyl complexes and docking studies with dsDNA
2013 · Navaneetha Nambigari, Ramasree Dulapalli, et al. · Medicinal Chemistry Research · 16
Identification of small molecular ligands as potent inhibitors of fatty acid metabolism in Mycobacterium tuberculosis
2017 · Ramesh Malikanti, Rajender Vadija, et al. · Journal of Molecular Structure · 13
Modeling of Alternate RNA Polymerase Sigma D Factor and Identification of Novel Inhibitors by Virtual Screening
2012 · Vasavi Malkhed, Kiran Kumar Mustyala, et al. · Cellular and Molecular Bioengineering · 10
Pharmacophore mapping and in silico screening to identify new potent leads for A2Aadenosine receptor as antagonists
2012 · Kiran Kumar Mustyala, Annapurna Renee Chitturi, et al. · Journal of Receptors and Signal Transduction · 10
Macromolecular structure and interaction studies of SigF and Usfx inMycobacterium tuberculosis
2014 · Kiran Kumar Mustyala, Vasavi Malkhed, et al. · Journal of Receptors and Signal Transduction · 9
Structure Elucidation and Identification of Novel Lead Molecules against Sulfur Import Protein cysA of Mycobacterium tuberculosis
2023 · Mounika Badineni, Vasavi Malkhed, et al. · Current Protein and Peptide Science · 7
Identification of novel scaffolds to inhibit Mycobacterium tuberculosis PimA protein—A computational approach
2023 · Thirupathi Damera, Vani Kondaparthi, et al. · Journal of Cellular Biochemistry · 7
Virtual screening studies to identify novel inhibitors for Sigma F protein of Mycobacterium tuberculosis
2015 · Kiran Kumar Mustyala, Vasavi Malkhed, et al. · International Journal of Mycobacteriology · 7
Identification of Small Molecular Inhibitors for Efflux Protein: DrrA of Mycobacterium tuberculosis
2015 · Kiran Kumar Mustyala, Vasavi Malkhed, et al. · Cellular and Molecular Bioengineering · 6
Virtual Screening Technique to Identify Inhibitors of Mycobacterium tuberculosis Rv3032 Protein Involved in MGLP Biosynthesis
2024 · Lavanya Rumandla, Mounika Badineni, et al. · Russian Journal of Bioorganic Chemistry · 3
Identification of small molecular inhibitors for efflux protein Rv2688c of Mycobacterium tuberculosis
2018 · Rajender Vadija, Kiran Kumar Mustyala, et al. · Biotechnology and Applied Biochemistry · 2
An In Silico Design, Simulation, Virtual Screening, and Evaluation of Natural Products as Inhibitors of Breast Cancer-Causing Kallikrein11 Protein and Comparison of Binding Affinities with Approved Drugs
2026 · Vani Kondaparthi, Vasavi Malkhed, et al. · Current Drug Targets
Design of molecular inhibitors against the NuoC protein of Mycobacterium tuberculosis
2024 · Hareesh Reddy Badepally, Lavanya Rumandla, et al. · International Journal of Pharmaceutical Sciences and Drug Research
PDF
Works count: 16
Citation count: 150
H-index: 8
I10-index: 7
Year
Topic
Type